Optimizing adipose-derived stem cell therapy for diabetic foot ulcers

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 11

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Diabetes. Nov 15, 2025; 16(11): 109859
Published online Nov 15, 2025. doi: 10.4239/wjd.v16.i11.109859

Table 2 Grouping of experimental rats

ADSCs: Adipose-derived mesenchymal stem cells.

Citation: Cao J, Liu ZC, An WQ, Zhang S, Zhang X, Li LJ, Ji HL, Long X, Yang YM. Optimizing adipose-derived stem cell therapy for diabetic foot ulcers. World J Diabetes 2025; 16(11): 109859
URL: https://www.wjgnet.com/1948-9358/full/v16/i11/109859.htm
DOI: https://dx.doi.org/10.4239/wjd.v16.i11.109859

Cao J, Liu ZC, An WQ, Zhang S, Zhang X, Li LJ, Ji HL, Long X, Yang YM. Optimizing adipose-derived stem cell therapy for diabetic foot ulcers. World J Diabetes 2025; 16(11): 109859 [PMID: 41278441 DOI: 10.4239/wjd.v16.i11.109859]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.